ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools
BOULDER, Colo., Dec. 22, 2023 (GLOBE NEWSWIRE) — SomaLogic, Inc., a leader in proteomics technology, today announced that Institutional Shareholder […]
Super League Announces Private Placement Financing of $8.354 Million and Enters into Accounts Receivable Facility to Further Fund Growth Initiatives
SANTA MONICA, Calif., Dec. 22, 2023 (GLOBE NEWSWIRE) — Super League (Nasdaq: SLE), a global leader in providing immersive experiences […]
Millicom (Tigo) share repurchase activity
Millicom (Tigo) share repurchase activity Luxembourg, December 22, 2023 – Pursuant to the share repurchase program announced on December 15, […]
TSX News -
Constellation Software’s Harris Operating Group Acquires MEDHOST, Inc.
TORONTO, Dec. 22, 2023 (GLOBE NEWSWIRE) — Constellation Software Inc. (“Constellation”) (TSX:CSU), today announced its wholly-owned subsidiary N. Harris Computer […]
Vortex Closes Flow-Through Portion of Private Placement for Gross Proceeds of C$1M
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. […]
AYR Announces Receipt of Senior Noteholder and Court Approval of Previously Announced Plan of Arrangement
MIAMI, Dec. 22, 2023 (GLOBE NEWSWIRE) — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically […]
Stallion Uranium Closes Non-Brokered Private Placement Financing
VANCOUVER, British Columbia, Dec. 22, 2023 (GLOBE NEWSWIRE) — Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; […]
KULR Receives Non-Compliance Notice from NYSE American
Company to Deliver Plan of Compliance to NYSE American SAN DIEGO, Dec. 22, 2023 (GLOBE NEWSWIRE) — KULR Technology Group, […]
Osino Announces Closing of Bridge Private Placement of Common Shares
VANCOUVER, British Columbia, Dec. 22, 2023 (GLOBE NEWSWIRE) — Osino Resources Corp. (TSXV:OSI) (NSX:OSN) (FSE:RSR1) (OTCQX:OSIIF) (“Osino” or the “Company“) […]
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SAN CARLOS, Calif., Dec. 22, 2023 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, […]
